Pharmacokinetics, efficacy, and safety of intravesical formulation of oxybutynin in patients with detrusor overactivity

Scandinavian Journal of Urology and Nephrology

Volumn 36, Issue 1, 2002, Pages 18-24

  Lehtoranta, Kari ^a   Tainio, Hanna ^a   Lukkari Lax, Eeva ^a   Hakonen, Tiina ^a   Tammela, Teuvo L J ^a  

^a PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

Author keywords

Anticholinergic drugs; Drug effects; Pharmacokinetics; Urinary instillations

Indexed keywords

DEETHYLOXYBUTYNIN; DRUG METABOLITE; OXYBUTYNIN; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLADDER IRRIGATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYSTOMETRY; DETRUSOR DYSSYNERGIA; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG FORMULATION; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; HUMAN; MALE; MICTURITION; PALLIATIVE THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URGE INCONTINENCE;

ADMINISTRATION, INTRAVESICAL; ADOLESCENT; ADULT; CHOLINERGIC ANTAGONISTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MANDELIC ACIDS; MIDDLE AGED; URINARY BLADDER, NEUROGENIC; URINARY INCONTINENCE; URODYNAMICS;

EID: 0036121332     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655902317259319     Document Type: Article

References (24)

1. The pharmacokinetics of oxybutynin in man
2. Low dose oxybutynin for the unstable bladder
3. Relaxation of intestinal bladders by intravesical oxybutynin chloride
4. The pharmacokinetics of intravesical and oral oxybutynin chloride
5. Expanded follow up of intravesical oxybutynin chloride use in children with neurogenic bladder
6. Complications of intravesical oxybutynin chloride therapy in the pediatric myelomeningocele population
7. Intravesical oxybutynin for neurogenic bladder dysfunction: Less systemic side effects due to reduced first pass metabolism
8. Intravesical application of a stable oxybutynin solution improves therapeutic compliance and acceptance in children with neurogenic bladder dysfunction
9. Control of detrusor hyperreflexia by the intravesical instillation of oxybutynine hydrochloride
10. Intravesical application of oxybutynine: Mode of action in controlling detrusor hyperreflexia
11. Topical oxybutynin chloride for relaxation of dysfunctional bladders
12. Effect of intermittent urethral catheterization and oxybutynin bladder instillation on urinary continence status and quality of life in a selected group of spinal cord injury patients with neuropathic bladder dysfunction
13. Intravesical oxybutynin chloride: Experience with 42 patients
14. Intravesical oxybutynin for spinal cord injury patients
15. The use of intravesical oxybutynin chloride in patients with detrusor hypertonicity and detrusor hyperreflexia
16. Early cystometrograms can predict the response to intravesical instillation of oxybutynin chloride in myelomeningocele patients
17. The standardisation of terminology of lower urinary tract function
18. Antimuscarinic activity of oxybutynin in the human plasma quantitated by a radioreceptor assay
19. Pharmacokinetics and effects of intravesical oxybutynin on the paediatric neurogenic bladder
20. Long-term intravesical oxybutynin chloride therapy in children with myelodysplasia
21. Dosage escalation of intravesical oxybutynin in the treatment of neurogenic bladder patients
22. Combined intravesical and oral oxybutynin chloride in adult patients with spinal cord injury
23. The use of intravesical oxybutynin chloride in children with neurogenic bladder
24. Follow-up of longtime treatment with intravesical oxybutynin for neurogenic bladder in children